Clinical Trials Logo

Blood Loss, Surgical clinical trials

View clinical trials related to Blood Loss, Surgical.

Filter by:

NCT ID: NCT05391607 Completed - Clinical trials for Blood Loss, Surgical

Comparison Between Hyperoncotic and Isooncotic Albumin to Support Blood Loss Replacement

VASCALB
Start date: May 25, 2022
Phase: Phase 4
Study type: Interventional

Fluid intravascular replacement is usually performed with either balanced crystalloids or iso-oncotic colloids, (synthetic colloids, plasma and 5% albumin). Doubts have been raised about synthetic colloids, and albumin solutions have been used more extensively. Albumin is the main protein responsible for plasma oncotic pressure and its volume expansion effect. The mobilization of extravascular fluid by infusing a hyper-oncotic solution like 20% albumin solution has been shown, causing endogenous fluid recruitment and blood volume expansion. The primary objective of this study is to compare the effect on plasma volume expansion and fluid recruitment of 3 different types of fluids (Albumin 5% and Albumin 20% and Ringer-lactate) during the hemorrhagic phase of the cystectomy procedure. Secondary objectives are the assessment of the hemodynamic parameters during surgery and the follow-up of pro-ANP and pro-BNP peptides. Glycocalyx proteins will be followed to evaluate endothelial wall shedding and microcirculation damages.

NCT ID: NCT05385952 Completed - Liver Diseases Clinical Trials

GATT-Patch Versus TachoSil in Liver Surgery

Start date: August 4, 2022
Phase: N/A
Study type: Interventional

This is a pre-market, prospective, randomized (2:1), multicenter, multi-national pivotal clinical investigation. The purpose of this investigation is to determine the clinical safety and performance of GATT-Patch as compared with TachoSil for the management of minimal, mild, or moderate bleeding during elective open liver surgery.

NCT ID: NCT05273632 Completed - Clinical trials for Blood Loss, Surgical

Comparison Study of Oxytocin Versus Tranexamic Acid and Etamsylaye Versus Placebo(Saline)

Start date: March 20, 2022
Phase: N/A
Study type: Interventional

Comparison Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate Versus Normal Saline as Pre-operative Administration.

NCT ID: NCT05258487 Completed - Clinical trials for Intraoperative Blood Loss

The Utility of the Validated Intraoperative Bleeding Scale in Spine Surgery

Start date: March 1, 2022
Phase:
Study type: Observational

This is a single-center, prospective, observational study that will compare the blood transfusion rate between intraoperative bleeding severity characterized using the Validated Intraoperative Bleeding Scale (VIBe).

NCT ID: NCT05108597 Completed - Clinical trials for Blood Loss, Surgical

Effect of Rectal Misoprostol in Reducing Intra-operative Blood Loss During Myomectomy

Start date: March 4, 2019
Phase: Phase 3
Study type: Interventional

A total of 200 women for elective abdominal myomectomy were randomly allocated into two groups. 100 women in experimental group were administered 400ug Misoprostol (2 tablets of Prosotec®) through the rectal route prior to surgery and 100 were in control group, in which no drug was administered.

NCT ID: NCT05035303 Completed - Clinical trials for Blood Loss, Surgical

Can Trajectory Nor-epinephrine Infiltration Reduce Blood Loss During Percutaneous Nephrolithotomy (PCNL)?

Start date: March 10, 2020
Phase: N/A
Study type: Interventional

during PCNL; A few milliliters of nor-epinephrine is injected into the intended tract after puncture of pelvicalyceal system and before its dilatation compared to injection of saline (placebo). hemoglobin change & blood loss is estimated and will compared.

NCT ID: NCT04976530 Completed - Clinical trials for Blood Loss, Surgical

Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)

STAR-T
Start date: August 31, 2021
Phase: N/A
Study type: Interventional

Prospective, multi-center, double-blind, randomized pivotal trial to evaluate the safety and effectiveness of the DrugSorb-ATR system for intraoperative removal of ticagrelor in patients undergoing urgent cardiothoracic (CT) surgery with cardiopulmonary bypass (CPB).

NCT ID: NCT04925843 Completed - Clinical trials for Liver Transplant; Complications

Fibrinogen and Intraoperative Bleeding in Liver Transplant

FIB_TOF
Start date: July 15, 2019
Phase:
Study type: Observational

Liver transplantation is the only treatment for end-stage liver disease. It is a high-risk surgery that can cause heavy intraoperative bleeding. Bleeding and transfusions of blood products are themselves associated with several postoperative complications. Few data have suggested beneficial interventions that can decrease this bleeding. Such interventions are necessary in order to improve these patients' outcomes. In order to better understand the potential therapeutic targets, a better comprehension of the variables associated with such bleeding is essential. Several previous studies have demonstrated a weak association between usual clotting times and bleeding in this population. However, few studies have evaluated the association between the concentration of fibrinogen and bleeding in this population. The primary objective of this study is to assess the association between preoperative serum fibrinogen concentration and the volume of intraoperative bleeding. The secondary objective is to assess the association between preoperative serum fibrinogen concentration and the number of red blood cell units transfused during the intraoperative and immediate postoperative periods. The hypothesis of the study is that a low concentration of preoperative fibrinogen will be associated with an increase in intraoperative bleeding and red blood cell transfusions.

NCT ID: NCT04819945 Completed - Clinical trials for Hemorrhage, Surgical

Clinical Safety and Performance of GATT-Patch in Open Liver Surgery

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the clinical safety and performance of GATT-Patch for management of haemorrhage during elective open liver surgery.

NCT ID: NCT04656067 Completed - Clinical trials for Blood Loss, Surgical

Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate

Start date: April 1, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate, Pre-operative Administration.